Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124215182 | 12421518 | 2 | F | 20160620 | 20160531 | 20160704 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041686 | BRISTOL MYERS SQUIBB | 1.00 | DY | Y | 2.30000 | KG | 20160704 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124215182 | 12421518 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 6 MG, QD | U | 21436 | 6 | MG | TABLET | QD | |||||
| 124215182 | 12421518 | 2 | SS | DIAZEPAM. | DIAZEPAM | 1 | Transplacental | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 124215182 | 12421518 | 3 | SS | DIAZEPAM. | DIAZEPAM | 1 | Transplacental | 5 MG, QD | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124215182 | 12421518 | 1 | Product used for unknown indication |
| 124215182 | 12421518 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124215182 | 12421518 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124215182 | 12421518 | Foetal exposure during pregnancy | |
| 124215182 | 12421518 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |